back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Recent filings | ||||||
| Filed 2026-04-01 14:22 Tx date 2026-03-31 |
$RX
BioSyent Inc. |
Arcuri, Joseph
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$2,696
+187 vol $14.42 each |
14,016 | |
| Filed 2026-04-01 14:21 Tx date 2026-03-31 |
$RX
BioSyent Inc. |
Arcuri, Joseph
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
-374 vol |
13,829 | |
| Older filings | ||||||
| Filed 2026-03-25 04:15 Tx date 2026-03-24 |
$RX
BioSyent Inc. |
Arcuri, Joseph
4 - Director of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
+360 vol |
14,203 | |
| Filed 2026-03-17 09:37 Tx date 2025-12-31 |
$RX
BioSyent Inc. |
Arcuri, Joseph
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$697.16
+58 vol $12.02 each |
13,843 | |
| Filed 2026-03-17 09:36 Tx date 2025-12-31 |
$RX
BioSyent Inc. |
Arcuri, Joseph
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$2,576
+229 vol $11.25 each |
13,785 | |
| Filed 2026-01-02 10:00 Tx date 2025-12-31 |
$RX
BioSyent Inc. |
Arcuri, Joseph
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$1,794
+141 vol $12.73 each |
13,556 | |
| Filed 2026-01-02 09:59 Tx date 2025-12-31 |
$RX
BioSyent Inc. |
Arcuri, Joseph
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+282 vol |
13,415 | |
| Filed 2025-10-01 10:51 Tx date 2025-09-30 |
$RX
BioSyent Inc. |
Arcuri, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$1,615
+140 vol $11.54 each |
13,133 | |
| Filed 2025-10-01 10:50 Tx date 2025-09-30 |
$RX
BioSyent Inc. |
Arcuri, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
-281 vol |
12,993 | |
| Filed 2025-07-03 03:35 Tx date 2025-06-30 |
$RX
BioSyent Inc. |
Arcuri, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$1,652
+140 vol $11.80 each |
13,274 | |
| Filed 2025-07-03 03:34 Tx date 2025-06-30 |
$RX
BioSyent Inc. |
Arcuri, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+280 vol |
13,134 | |
| Filed 2025-04-01 09:22 Tx date 2025-03-31 |
$RX
BioSyent Inc. |
Arcuri, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$1,549
+139 vol $11.15 each |
12,854 | |
| Filed 2025-04-01 09:21 Tx date 2025-03-31 |
$RX
BioSyent Inc. |
Arcuri, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+279 vol |
12,715 | |
| Filed 2025-03-19 09:40 Tx date 2025-03-18 |
$RX
BioSyent Inc. |
Arcuri, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
+420 vol |
12,436 | |
| Filed 2025-03-13 12:54 Tx date 2025-01-31 |
$RX
BioSyent Inc. |
Arcuri, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$689.92
+77 vol $8.96 each |
12,016 | |
| Filed 2025-03-13 12:53 Tx date 2024-12-31 |
$RX
BioSyent Inc. |
Arcuri, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,768
+185 vol $9.56 each |
11,939 | |
| Filed 2025-01-02 13:20 Tx date 2024-12-31 |
$RX
BioSyent Inc. |
Arcuri, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$1,760
+160 vol $11.00 each |
11,754 | |
| Filed 2025-01-02 13:19 Tx date 2024-12-31 |
$RX
BioSyent Inc. |
Arcuri, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+321 vol |
11,594 | |
| Filed 2024-10-03 14:46 Tx date 2024-09-30 |
$RX
BioSyent Inc. |
Arcuri, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$1,713
+160 vol $10.71 each |
11,273 | |
| Filed 2024-10-03 14:45 Tx date 2024-09-30 |
$RX
BioSyent Inc. |
Arcuri, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+320 vol |
11,113 | |